Search - tctmd.com

Displaying 101 - 120 of 313

Sort: Relevancy | Date

Presentation TCT 2019

Utility and Risks of Vena Cava Filters to Prevent PE

Presenter: Riyaz Bashir

September 26, 2019

Presentation TCT 2019

Emerging Safety Signals and FDA’s Medical Device Safety Action Plan: Responses to the Late Mortality Signal

Presenter: Rebecca Ward

September 26, 2019

Presentation TCT 2019

Catheter-Directed Therapy for Acute PE II: Indications, Options, Outcomes

Presenter: Thomas Tu

September 26, 2019

Presentation TCT 2019

Potential Study Designs to Address the Mortality Safety Signal

Presenter: Laura Mauri

September 26, 2019

Presentation TCT 2019

Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward

Presenter: Sahil Parikh

September 26, 2019

Presentation TCT 2019

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Presenter: Ian Meredith AM

September 26, 2019

Presentation TCT 2019

Systemic Therapy for Acute PE: Options, Effectiveness, Safety

Presenter: Jay Giri

September 26, 2019

Presentation TCT 2019

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Presenter: Elazer Edelman

September 26, 2019

Presentation TCT 2019

PERT: Why and How

Presenter: Robert Lookstein

September 26, 2019

Presentation TCT 2019

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

Presenter: Krishna Rocha-Singh

September 26, 2019

Presentation TCT 2019

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Presenter: Konstantinos Katsanos

September 26, 2019

Presentation TCT 2019

Diagnosing Pulmonary Embolism: A Practical Approach

Presenter: Ido Weinberg

September 26, 2019

Presentation TCT 2019

Preventing PE in the Cardiac Patient: What Therapies and for Whom?

Presenter: Herbert Aronow

September 26, 2019

Presentation TCT 2019

Catheter-Directed Therapy for Acute PE I: Indications, Options, Outcomes

Presenter: Vikas Aggarwal

September 26, 2019

Presentation TCT 2019

1-Year Late Lumen Loss With a Polymer-Coated Paclitaxel-Eluting Stent and a Polymer-Free Paclitaxel-Coated Stent for Femoropopliteal Disease: Study Results

Presenter: Daizo Kawasaki

September 26, 2019

Presentation TCT 2019

Optimal Vessel Preparation Evaluated by Multimodality Imaging: Results From IGNITE

Presenter: Masahiko Fujihara

September 26, 2019

Presentation TCT 2019

New Crossing Techniques for Complex Femoropopliteal Disease

Presenter: Makoto Utsunomiya

September 26, 2019

Presentation TCT 2019

Mortality Risk Following Application of Paclitaxel-Coated Devices in Femoropopliteal Lesion: Results From the CAROOT Study

Presenter: Yoshimitsu Soga

September 26, 2019

Presentation TCT 2019

Intravascular Ultrasound Supported Endovascular Therapy in SFA Disease: 12-Month Results From the IVORY Study

Presenter: Osamu Iida

September 26, 2019

Presentation TCT 2019

Introduction

Presenter: Masato Nakamura

September 26, 2019

Advertisement

Utility and Risks of Vena Cava Filters to Prevent PE

Emerging Safety Signals and FDA’s Medical Device Safety Action Plan: Responses to the Late Mortality Signal

Catheter-Directed Therapy for Acute PE II: Indications, Options, Outcomes

Potential Study Designs to Address the Mortality Safety Signal

Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Systemic Therapy for Acute PE: Options, Effectiveness, Safety

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

PERT: Why and How

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Diagnosing Pulmonary Embolism: A Practical Approach

Preventing PE in the Cardiac Patient: What Therapies and for Whom?

Catheter-Directed Therapy for Acute PE I: Indications, Options, Outcomes

1-Year Late Lumen Loss With a Polymer-Coated Paclitaxel-Eluting Stent and a Polymer-Free Paclitaxel-Coated Stent for Femoropopliteal Disease: Study Results

Optimal Vessel Preparation Evaluated by Multimodality Imaging: Results From IGNITE

New Crossing Techniques for Complex Femoropopliteal Disease

Mortality Risk Following Application of Paclitaxel-Coated Devices in Femoropopliteal Lesion: Results From the CAROOT Study

Intravascular Ultrasound Supported Endovascular Therapy in SFA Disease: 12-Month Results From the IVORY Study

Introduction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content